The effect of cancer on survival in people with Sjogren's disease was substantial, Rusinovich pointed out. Malignancies ...

Please provide your email address to receive an email when new articles are posted on . Patients with early-stage classic Hodgkin lymphoma and other neoplasms exhibited higher risk for cardiovascular ...

Hodgkin lymphoma, also called Hodgkin disease, is one of the two main kinds of lymphoma. (The other is non-Hodgkin lymphoma.) Most people with Hodgkin lymphoma have what is called the “classical” type ...

Epcoritamab, rituximab, and lenalidomide combination is approved for relapsed/refractory follicular lymphoma, marking a first in bispecific antibody second-line treatments. The EPCORE FL-1 study ...

Ahead of the upcoming American Society of Hematology annual meeting, a multicenter study published in the Journal of Clinical ...

The progression of disease after first-line treatment reduces overall survival and increases all-cause mortality in patients ...

The Cutaneous Lymphoma Foundation connects patients with guidance and resources for this rare cancer. THE CORRECT TREATMENT AND team are key components to fighting cancer, and support is equally ...

We report herein a case of thyroid mucosa-associated lymphoid tissue (MALT) lymphoma in a patient receiving antithyroid drug therapy for Graves' disease. A 75-year-old woman first presented with ...

Epkinly plus rituximab and lenalidomide is the first bispecific antibody combination FDA-approved for relapsed or refractory follicular lymphoma, backed by Phase III data showing substantially ...

Autoimmune diseases (AIs) are associated with elevated risk for Hodgkin's lymphoma (HL); however, information on the interplay of AIs and HL on survival is sparse. Patients with HL have an overall ...